# First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-everolimus-and-cisplatin-in-patients-with-advanced-extrapulmonary/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sonja Levy,Wieke H.M. Verbeek,Ferry A.L.M. Eskens,José G. van den Berg,Derk Jan A. de Groot,Monique E. van Leerdam,Margot Tesselaar |
| Citations | 11 |
| DOI | 10.1177/17588359221077088 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.sagepub.com/doi/pdf/10.1177/17588359221077088 |
| OpenAlex ID | https://openalex.org/W4214581937 |
| PMID | 35251315 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Sonja Levy](https://scholariq.org/researchers/sonja-levy/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.